Emilin1 Links TGF-β Maturation to Blood Pressure Homeostasis

Cell - Tập 124 - Trang 929-942 - 2006
Luca Zacchigna1, Carmine Vecchione2, Antonella Notte2, Michelangelo Cordenonsi1, Sirio Dupont1, Silvia Maretto1, Giuseppe Cifelli2, Alessandra Ferrari3, Angelo Maffei2, Carla Fabbro3, Paola Braghetta3, Gennaro Marino2, Giulio Selvetella2, Alessandra Aretini2, Claudio Colonnese2, Umberto Bettarini2, Giovanni Russo2, Sandra Soligo1, Maddalena Adorno1, Paolo Bonaldo3
1Developmental Signaling Laboratory, Department of Histology Microbiology and Medical Biotechnologies, University of Padua, viale Colombo 3, 35121 Padua, Italy
2Department of Angiocardioneurology, I.R.C.C.S. Neuromed Institute, Loc. Camerelle, 86077 Pozzilli (IS), Italy
3Mouse Genetics Laboratory, Department of Histology Microbiology and Medical Biotechnologies, University of Padua, viale Colombo 3, 35121 Padua, Italy

Tài liệu tham khảo

Agrotis, 2005, Transforming growth factor-beta, cell signaling and cardiovascular disorders, Curr Vasc Pharmacol, 3, 55, 10.2174/1570161052773951 Annes, 2003, Making sense of latent TGFbeta activation, J. Cell Sci., 116, 217, 10.1242/jcs.00229 Beck, 2002, Extraembryonic proteases regulate Nodal signalling during gastrulation, Nat. Cell Biol., 4, 981, 10.1038/ncb890 Braghetta, 2004, Overlapping, complementary and site-specific expression pattern of genes of the EMILIN/Multimerin family, Matrix Biol., 22, 549, 10.1016/j.matbio.2003.10.005 Bressan, 1993, Emilin, a component of elastic fibers preferentially located at the elastin-microfibrils interface, J. Cell Biol., 121, 201, 10.1083/jcb.121.1.201 De Acetis, 2005, Cardiac overexpression of melusin protects from dilated cardiomyopathy due to long-standing pressure overload, Circ. Res., 96, 1087, 10.1161/01.RES.0000168028.36081.e0 Dietz, 1991, Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene, Nature, 352, 337, 10.1038/352337a0 Eimon, 2002, Effects of heterodimerization and proteolytic processing on Derriere and Nodal activity: implications for mesoderm induction in Xenopus, Development, 129, 3089, 10.1242/dev.129.13.3089 Faury, 2003, Developmental adaptation of the mouse cardiovascular system to elastin haploinsufficiency, J. Clin. Invest., 112, 1419, 10.1172/JCI19028 Inman, 2002, SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7, Mol. Pharmacol., 62, 65, 10.1124/mol.62.1.65 Izzo, 2001, Arterial stiffness: clinical relevance, measurement, and treatment, Rev. Cardiovasc. Med., 2, 29 Khanna, 2004, Concerted effect of transforming growth factor-beta, cyclin inhibitor p21, and c-myc on smooth muscle cell proliferation, Am. J. Physiol. Heart Circ. Physiol., 286, H1133, 10.1152/ajpheart.00462.2003 Koli, 2004, Disruption of LTBP-4 function reduces TGF-beta activation and enhances BMP-4 signaling in the lung, J. Cell Biol., 167, 123, 10.1083/jcb.200403067 Mongiat, 2000, Self-assembly and supramolecular organization of EMILIN, J. Biol. Chem., 275, 25471, 10.1074/jbc.M001426200 Mulvany, 2002, Small artery remodeling and significance in the development of hypertension, News Physiol. Sci., 17, 105 Neptune, 2003, Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome, Nat. Genet., 33, 407, 10.1038/ng1116 Piccolo, 1999, The head inducer Cerberus is a multifunctional antagonist of Nodal, BMP and Wnt signals, Nature, 397, 707, 10.1038/17820 Siegel, 2003, Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer, Nat. Rev. Cancer, 3, 807, 10.1038/nrc1208 Staessen, 2003, Essential hypertension, Lancet, 361, 1629, 10.1016/S0140-6736(03)13302-8 Suthanthiran, 2000, Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage, Proc. Natl. Acad. Sci. USA, 97, 3479 Ventura, 2004, JNK regulates autocrine expression of TGF-beta1, Mol. Cell, 15, 269, 10.1016/j.molcel.2004.06.007 Zanetti, 2004, EMILIN-1 deficiency induces elastogenesis and vascular cell defects, Mol. Cell. Biol., 24, 638, 10.1128/MCB.24.2.638-650.2004